Evidence map›Paper›PMID 34604271›Full record

ArticleFrontiers in nutrition2021

Mechanism of

Zhiqiang Luo, Yang Liu, Xing Han, Wenning Yang, Guopeng Wang, Jing Wang, Xiaoquan Jiang, Muli Sen, Xueyan Li, Guohua Yu and 1 more

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Rapid identification of chemical profilesFrontiers in pharmacology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Integrated Strategy FromFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhiqiang LuoSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Yang LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Xing HanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Wenning YangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Guopeng WangZhongcai Health (Beijing) Biological Technology Development Co., Ltd., Beijing, China.
Jing WangState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Xiaoquan JiangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Muli SenSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Xueyan LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Guohua YuSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Yuanyuan ShiSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening functional food ingredients (FFI) from medicinal and edible plants (MEP) has still remained a great challenge due to the complexity of MEP and its obscure function mechanisms. Herein, an integrated strategy based on sequential metabolites identification approach, network pharmacology, molecular docking, and surface plasmon resonance (SPR) analysis was proposed for quickly identifying the active constituents in MEP. First, the sequential biotransformation process of MEP, including intestinal absorption and metabolism, and hepatic metabolism, was investigated by oral gavage, and intestinal perfusion with venous sampling method. Then the blood samples were analyzed by UPLC-Q Exactive Orbitrap HRMS. Second, the network pharmacology approach was used to explore the potential targets and possible mechanisms of the

Indexed as

network pharmacologynon-alcoholic fatty liver diseasePaeoniae Radix Albasequential metabolismsurface plasmon resonanceUPLC-Q Exactive Orbitrap HRMS

Identifiers

PMID34604271
PMCPMC8481579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.